Original research: primary research from any area of Clinical Pharmacology and Toxicology

Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.

Editorial: to introduce and comment on major advances and developments in the field.

Methodology: present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested ideally, but not necessarily, used in a way that proves its value.

News and commentary: short, focused and opinionated articles on any subject with in the journal’s scope. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion of leaders invited by the editorial board. Editorial board members and section editors may write such articles to highlight hot or emerging areas of research within a given field.

Rapid communications: devoted to the publication of short papers presenting highly original and significant material.

Review: to review systematically progress and unresolved problems in the field and make suggestions for future work. Comprehensive, authoritative, descriptions of any subject within the scope of Clinical Pharmacology and Toxicology journal.

Short reports: brief reports of data from original research.

Letters to the Editor: to discuss and make reply to the contributions published in JCPT, or to introduce and comment on a controversial issue of general interest.

All articles of JCPT are posted online immediately as they are ready for publication. All articles will be assigned a DOI number (Digital Object Identifier) where they become searchable and citeable without delay.

• JCPT offers scientists the opportunity to publish their research rapidly in an open access medium that is freely available online to researchers worldwide.
• Electronic submission of manuscripts.
• Immediate publication tentatively within a month/two months of Initial submission.
• Efficient and objective peer review with a streamlined electronic production workflow.
• No barriers, which helps your research reach the entire scientific community worldwide.
• Our professional staff adds further value to your paper through the copy-editing process, which minimize stylistic errors and improves readability.
• Our professional staff continuously working to improve the search engine rankings for NobleResearch group journals.
• Our linking program extends too many abstracting and indexing databases, library sites, and includes participation in CrossRef^TM.

Peer-review is commonly accepted as an essential part of scientific publication. We appreciate the time that referees devote to assessing the manuscripts we send them, which helps to ensure that NobleResearch journals publish only material of the highest quality. Peer reviewers are asked to give their opinion on a number of issues pertinent to the scientific and formal aspects of a paper, and to judge the papers on grounds of originality and urgency. All relevant information will be forwarded to the author(s). There are several types of decision possible for each article.

• Accept manuscript without revision
• Accept after minor or major revision
• Submit elsewhere, if the manuscript is better suited for another journal in our group
• Reject manuscript, if the manuscript is substandard

In addition, papers may be rejected directly by the Chief Editor if judged to be out of scope or if scientifically or formally sub-standard. When asking for revisions, reviewers have two possible goals: to ask authors to tighten their arguments based on existing data, or to identify areas where more data are needed. Even formal revision may be required if the language or formalities is sub-standard. To facilitate rapid publication, authors are given a maximum of two months for revision. After two months, revised manuscripts will be considered as new submissions.

The review process is strictly confidential and should be treated as such by reviewers. Because the author may have chosen to exclude some people from this process, no one not directly involved with the manuscript, including colleagues or other experts in the field, should be consulted by the reviewer unless such consultations have first been discussed with the professional editor.

NobleResearch believes that an efficient editorial process that results in timely publication provides a valuable service both to authors and to the scientific community at large. We therefore request that reviewers respond promptly, usually within fourteen (14) days of receipt of a manuscript. If reviewers need more time, we request that they contact us promptly so that we can keep the authors informed and, if necessary, assign alternative reviewers.

Authors may and should take advantage of the web-based nature of the publication by submitting supplemental files that include animations, software demonstrations and innovative graphics. Supplemental files will be evaluated with the manuscript as part of the peer-review process. They should not exceed 20 megabytes in size. We accept the following file formats for supplemental files: TIF (tif), JPEG (jpg), GIF (gif), Animated GIF (gif), PostScript (ps), Encapsulated PostScript (eps), Adobe Photoshop (psd), AdobePDF (pdf), Audio (au), Audio (mp3), Audio (wav), MPEG (mpg), Quicktime (avi), Quicktime (mov).

You keep the copyright of your article. You are free to print out copies of your article, email it to your colleagues and/or post it on the web. Your colleagues can use and disseminate your work without restriction for educational and scientific purposes.

Journal of Clinical Pharmacology and Toxicology offers a wide range of advertising opportunities to promote your product or service. NobleResearch group reserves the right to reject any advertisement not considered suitable for publication.

For more information please contact:

Marketing Director
Email: marketing@nobleresearch.org